Vogel VG, et al. (2006). Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NASBP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA, 295(23): 2727–2741.
|By:||Reference Healthwise Staff||Last Revised: November 6, 2012|
|Medical Review:||Reference Kathleen Romito, MD - Family Medicine
Reference Carla J. Herman, MD, MPH - Geriatric Medicine